Exclusive Interview with Professor Yu-Sun Chang: Taiwan and the World-Leading Research in Cancer Biomarker, Chang Gung University
In the past, tissue biopsy was the major diagnostics for cancer. With advances in molecular diagnostics, scientists nowadays expect to achieve early detection and treatment of cancer by studying biomarkers such as genes and proteins in human body to enhance survival rate of cancer patients.
It's free! Log in now to read
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23